Clinical Trials Directory

Trials / Completed

CompletedNCT05332145

MAP to Health Pilot Study: A Physical Activity Intervention for Midlife Adults

Development and Proof-of-Concept Trial of a Meaning- and Theory-based Physical Activity Intervention

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
35 (actual)
Sponsor
HealthPartners Institute · Academic / Other
Sex
All
Age
40 Years – 64 Years
Healthy volunteers
Not accepted

Summary

The study has two aims: (1) to develop and examine the acceptability of the technological and theoretical frameworks of MAP to Health and (2) to determine whether MAP to Health is related to changes in theoretically identified mechanisms of behavior change (meaning salience, basic psychological needs satisfaction, and internal motivation). In an exploratory aim, the study will assess how the intervention and mechanisms of change are related to changes in physical activity. Participants will be adults in midlife (ages 40-64) who are insufficiently active, are interested in increasing physical activity, do not have contraindications to engaging in physical activity, and are patients in a large healthcare system in the Midwest.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMAP to HealthIn Phase 1, participants will complete the web-based interview and Aim 1 measures, assessing acceptability and usability of the intervention. The investigators will review whether the intervention appropriately gathers information needed to program theory-based, personalized text messages. After completing the measures, a list of text messages for that participant will be generated and sent to the participant for review. Participants will review the text messages and rate the extent to which the messages are personalized. In Phase 2, the investigators will conduct a proof-of-concept pilot trial in which participants will complete a 4-week pretest monitoring period and an 8-week pilot trial of the intervention, with assessments of Self-Determination Theory mechanisms and meaning salience at pretest (-4 weeks), baseline (0 weeks), midpoint (4 weeks) and posttest (8 weeks). In addition, participants will wear accelerometers to assess physical activity during the 12 weeks.

Timeline

Start date
2022-11-04
Primary completion
2023-05-03
Completion
2023-05-04
First posted
2022-04-18
Last updated
2023-12-06
Results posted
2023-12-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05332145. Inclusion in this directory is not an endorsement.